Scinai Immunotherapeutics (SCNI) Other Non Operating Income (2023 - 2026)

Scinai Immunotherapeutics has reported Other Non Operating Income for 3 years, with the latest figure at -$6.2 million in Q1 2026.

• Quarterly Other Non Operating Income changed N/A year-over-year to -$6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.5 million (changed N/A YoY) and the FY2024 annual result came in at $14.8 million, up 163888.89% from the prior year.
• Other Non Operating Income declined to -$6.2 million in Q1 2026 per SCNI's latest filing, from -$757000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $1.2 million in Q2 2023 and troughed at -$6.2 million in Q1 2026.
• A 3-year average of -$1.0 million and a median of $231000.0 in 2024 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 29.79% in 2024, down 164.87% in 2024.
• Over 3 years, Other Non Operating Income stood at $1.2 million in 2023, then slumped by 164.87% to -$757000.0 in 2024, then tumbled by 713.21% to -$6.2 million in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$6.2 million, -$757000.0, and $231000.0 for Q1 2026, Q2 2024, and Q1 2024 respectively.